Recombinant activated factor VII in the management of massive obstetric bleeding [2]

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 3, 2006, Pages 226-227

  Palomino, Miguel Ángel Prieto ^a,b   Chaparro, María José S ^a   Ruiz De Elvira, Maria José Z ^a   Curiel, Emilio B ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL MATERNO INFANTIL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; CASE REPORT; CESAREAN SECTION; FEMALE; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; LETTER; OBSTETRIC HEMORRHAGE; PLACENTA PREVIA; PRIORITY JOURNAL; SOLUTIO PLACENTAE; VAGINA BLEEDING;

ABRUPTIO PLACENTAE; CESAREAN SECTION; DRUG COSTS; FACTOR VII; FACTOR VIIA; FATAL OUTCOME; FEMALE; FETAL DEATH; HEMORRHAGE; HUMANS; POSTOPERATIVE HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS; SPAIN;

EID: 33645501790     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000220249.42907.ff     Document Type: Letter

References (8)

1. Bouwmeester FW. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003; 101:1174-1176.
2. Eikelboom JW, Bird R, Blythe D, Coyle L, Gan E, Harvey M, et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrin 2003; 14:713-717.
3. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51:431-439.
4. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 2003; 10:797-811.
5. Laffan M, O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy D, Smith OP. Analysis and results of recombinant factor VIIa extended-use registry. Blood Coagul Fibrin 2003; 14(Suppl 1):S35-S38.
6. Segal S, Shemesh IY, Blumenthal R, Yoffe B, Laufer N, Ezra Y, Levy I, Mazor M, Martinowitz U. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 2003; 268:266-267.
7. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening postpartum haemorrhage. Br J Anaesth 2005; 94:592-595.
8. Roberts HR. Recombinant factor VII (NovoSeven®) and the safety of treatment. Semin Hematol 2001; 38(Suppl 12):48-50.